# Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient

> **NCT02168387** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 39 (actual)

## Conditions studied

- Atelectasis

## Interventions

- **DEVICE:** continuous high frequency oscillator (CHFO)
- **DRUG:** Acetylcysteine
- **DRUG:** dornase alfa

## Key facts

- **NCT ID:** NCT02168387
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168387, "Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02168387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*